News

New data from Biogen reveals higher Spinraza doses may enhance motor function in SMA patients. Read more here.
Sarcopenia, which is a progressive and extensive decline in muscle mass and strength, is common with aging and estimated to ...
Sarcopenia, which is a progressive and extensive decline in muscle mass and strength, is common with aging and is estimated ...
Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 ...
ISS-based lab-on-a-chip model advances the understanding of muscle aging and degeneration in microgravity, guiding future therapeutic strategies.
Panelists discuss how spinal muscular atrophy (SMA) treatment will evolve over the next 5 years, likely incorporating ...
Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration.
Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator.
Sarcopenia, which is a progressive and extensive decline in muscle mass and strength, is common with aging and estimated to ...